Issue Contents:  Jun 15, 2009

• FDA Review of Gout Drug Sends Savient Stock Soaring
• Oscient to Cut Sales Force as it Weighs Possible Sale
• MicroRNA Replacement Via Gene Therapy Stops Liver Cancer Cold
• Allergy Therapeutics Adding £22.4M, Getting New CEO
• CDC Issues First Guidelines Governing Genetic Testing
• CombinatoRx Shares Juiced by Synavive Data Breakdown
• Other News To Note
• Clinic Roundup
• Financings Roundup

      The above issue is also available as one PDF File